Tag: Kardium
PULSE-EU: single-shot spherical array PFA catheter achieves good clinical efficacy at...
The treatment of atrial fibrillation (AF) via a novel, ‘single-shot’ spherical array approach to pulsed field ablation (PFA) has been found to achieve durable...
Kardium closes latest round of financing
Kardium, developer of the Globe mapping and ablation system for the treatment of atrial fibrillation (AF), has raised US$104 million in a new financing...
First US patients treated in PULSAR study of Globe pulsed field...
Kardium has announced today that the first US patients have been successfully treated in the PULSAR clinical study, using its Globe pulsed-field ablation system.
The...
First patients treated in Kardium PULSAR IDE study of Globe pulsed...
Kardium, a private medical device company that has developed the Globe pulsed field (PF) system for the treatment of atrial fibrillation (AF) using pulsed...
Kardium receives CE mark for its Globe Mapping and Ablation System
Kardium has received CE mark approval for its Globe Mapping and Ablation System for the treatment of atrial fibrillation (AF).
“This is an important milestone...
New financing to commercialise Globe system for treatment of atrial fibrillation
In a new financing round, Kardium has raised an undisclosed amount to fund commercial activities in Europe and Canada, and for clinical testing of the Globe...